GMO Benchmark-Free Allocation Fund
Data updated: 2026-09-29
C000110912 — GMO Benchmark-Free Allocation Fund. United States Multi-Cap / All-Cap Blend / Core Equity. Holdings, fees, performance and SEC filings.
C000110912 Fund Overview
GMO Benchmark-Free Allocation Fund is a US mutual fund managed by Gmo Trust, categorised as United States Multi-Cap / All-Cap Blend / Core Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Gmo Trust
- Category: United States Multi-Cap / All-Cap Blend / Core Equity
- Assets under management: $2.60B
- 1-year return: 10.6%
- SEC CIK: 0000772129
- SEC series ID: S000005485
- Share class ID: C000110912
C000110912 Investment Objective and Strategy
GMO Benchmark-Free Allocation Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Gmo Trust.
Investment objective
Positive total return.
Principal investment strategy
The Fund seeks annualized returns of 5% (net of fees) above the Consumer Price Index and expects annualized volatility (standard deviation) of 5-10%, each over a complete market cycle. GMO does not manage the Fund to, or control the Funds risk relative to, any securities index or securities benchmark. The Fund is a fund of funds and invests primarily in Implementation Fund, other series of GMO Trust whether now existing or created in the future, including the Fixed Income Funds and the Alternative Funds, and in GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO seeks to achieve the Funds investment objective by investing the Funds assets in asset classes GMO believes offer the most attractive risk-adjusted returns.
GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of such asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Funds holdings of particular asset classes in response to changes in GMOs investment outlook and its assessment of market valuations and may use redemptions or purchases of Fund shares to rebalance the Funds investments. The factors GMO considers and investment methods GMO uses can change over time. The Fund is permitted to invest in any asset class (e.g., U.S., non-U.S., and emerging market equity; U.S., non-U.S., and emerging market fixed income (including asset-backed securities and municipal bonds); and commodities), strategy (e.g., long/short and event-driven strategies), sector, country, or region, and at times may have substantial exposure to a single asset class, sector, country, region, issuer, or currency and companies with similar market capitalizations.
In addition, the Fund is not restricted in its exposure to any particular market and may invest in securities of companies of any market capitalization and, in the case of debt instruments, of any credit quality (including below investment grade securities, commonly referred to as high yield or junk bonds), maturity and duration. GMOs ability to shift investments among asset classes is not subject to any limits. The Fund typically has substantial exposure to derivatives and short-sales. Leverage is not a principal component of the Funds investment strategy. However, because of its derivative exposure, the Fund may at times have gross investment exposure in excess of its net assets (i.e., the Fund may be leveraged) and, therefore, may be subject to higher risk of loss during those times than if the Fund were not leveraged.
In seeking to achieve the Funds investment objective, GMO may invest a significant portion of the Funds net assets in cash and cash equivalents. In addition, the Fund may lend its portfolio securities. The Fund also may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds.
C000110912 Holdings
Top 6 holdings of GMO Benchmark-Free Allocation Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| GMO Implementation Fund | 83.70% |
| GMO Alternative Allocation Fund | 12.27% |
| GMO Opportunistic Income Fund | 1.88% |
| GMO Climate Change Fund | 1.11% |
| GMO High Yield Fund | 0.99% |
| State Street Global Advisors | 0.13% |
C000110912 Portfolio Allocation
Asset-class allocation of GMO Benchmark-Free Allocation Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.9% |
| Cash & Equivalents | 0.1% |
C000110912 Performance
Total returns for C000110912 (as of 2026-10-01), from SEC filings.
| Period | Total return |
|---|---|
| 1 year | 10.6% |
| 3 years (annualised) | 3.9% |
C000110912 Risk Information
Risk metrics for C000110912, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 8.9%
C000110912 Costs and Fees
C000110912 costs about $111 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.11%
- Gross expense ratio: 1.19%
- Portfolio turnover: 11%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
C000110912 Cashflows
Over the 12 months to 2026-05, GMO Benchmark-Free Allocation Fund had net outflows of $148.22M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-05 | −$3.67M |
| 2026-04 | −$2.99M |
| 2026-03 | −$18.37M |
| 2026-02 | −$33.80M |
| 2026-01 | −$15.65M |
| 2025-12 | $3.20M |
C000110912 Debt Constituents
No individual debt constituents are reported in GMO Benchmark-Free Allocation Fund's latest SEC N-PORT filing.
C000110912 Prospectus and SEC Filings
Official GMO Benchmark-Free Allocation Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2026-09-29
- Prospectus (485BPOS) — filed 2026-06-30
- Prospectus supplement (497) — filed 2026-04-29
- Portfolio holdings (N-PORT) — filed 2026-07-29
- Portfolio holdings (N-PORT) — filed 2026-04-29
- Portfolio holdings (N-PORT) — filed 2026-01-29
- Annual census (N-CEN) — filed 2026-05-13
- Annual census (N-CEN) — filed 2025-05-13
Related Funds
Other United States Multi-Cap / All-Cap Blend / Core Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.